Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking
Lung squamous carcinomas (LUSC) are poorly molecularly characterized, but sub-populations show promising response to immune checkpoint inhibitors. Here, the authors identify a subset of LUSC characterized by infiltration of inflammatory monocytes, where metastasis is linked to Factor XIIIA promoting...
Main Authors: | Alessandro Porrello, Patrick L. Leslie, Emily B. Harrison, Balachandra K. Gorentla, Sravya Kattula, Subrata K. Ghosh, Salma H. Azam, Alisha Holtzhausen, Yvonne L. Chao, Michele C. Hayward, Trent A. Waugh, Sanggyu Bae, Virginia Godfrey, Scott H. Randell, Cecilia Oderup, Liza Makowski, Jared Weiss, Matthew D. Wilkerson, D. Neil Hayes, H. Shelton Earp, Albert S. Baldwin, Alisa S. Wolberg, Chad V. Pecot |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2018-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-04355-w |
Similar Items
-
Incorporation of albumin fusion proteins into fibrin clots <it>in vitro </it>and <it>in vivo</it>: comparison of different fusion motifs recognized by factor XIIIa
by: Sheffield William P, et al.
Published: (2011-12-01) -
Ethacrynic acid is an inhibitor of human factor XIIIa
by: Srabani Kar, et al.
Published: (2022-06-01) -
Factor XIII deficiency does not prevent FeCl3‐induced carotid artery thrombus formation in mice
by: Zhaoming Tang, et al.
Published: (2020-01-01) -
Mass Spectrometric Identification of a Novel Factor XIIIa Cross-Linking Site in Fibrinogen
by: Mariya E. Semkova, et al.
Published: (2021-11-01) -
Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase
by: Eric W. J. Gates, et al.
Published: (2023-02-01)